Concord Medical Services Stock (NYSE:CCM)


RevenueOwnershipFinancialsChart

Previous Close

$7.89

52W Range

$3.80 - $26.70

50D Avg

$6.71

200D Avg

$6.89

Market Cap

$33.87M

Avg Vol (3M)

$8.51K

Beta

-0.25

Div Yield

-

CCM Company Profile


Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. The company's other treatments and diagnostic services comprise computed tomography scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2021, it operated a network of 16 cooperative centers based in 13 hospitals. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

Show More

Industry

Medical - Care Facilities

Sector

Healthcare

Exchange

NYSE

ADR

Yes

Country

CN

Employees

727

IPO Date

Dec 11, 2009

Website

CCM Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
Medicine income$100.46M$85.71M$59.32M
Services and other revenues$500.07M$364.41M-
Equipment Leasing Revenues$16.74M$21.97M-
Medical service--$101.85M
Consumable and equipment sales--$217.38M
Management services and technical services--$64.60M

Fiscal year ends in Dec 23 | Currency in USD

CCM Financial Summary


Dec 23Dec 22Dec 21
Revenue$537.40M$472.08M$485.63M
Operating Income$-462.99M$-525.05M$-458.32M
Net Income$-297.66M$-768.99M$-522.67M
EBITDA$-344.16M$-581.17M$-331.40M
Basic EPS$-6.81$-17.60$-11.96
Diluted EPS$-6.81$-17.60$-11.96

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q2 16Aug 25, 16 | 9:31 AM
Q1 16May 24, 16 | 5:00 PM
Q4 15Mar 29, 16 | 5:00 PM

Peer Comparison


TickerCompany
TOIThe Oncology Institute, Inc.
INNVInnovAge Holding Corp.
PNTGThe Pennant Group, Inc.
EHABEnhabit, Inc.
SNDASonida Senior Living, Inc.
JYNTThe Joint Corp.
EHCEncompass Health Corporation
SEMSelect Medical Holdings Corporation
ENSGThe Ensign Group, Inc.